Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence
Journal of Neurochemistry · 2024
DOI: 10.1111/jnc.15964 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, 2024. Verfasst von Eddy Sokolaj und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pain Management Research Institute, Kolling Institute of Medical Research, Northern Clinical School, Royal North Shore Hospital, University of Sydney…. Hauptthemen laut MEDLINE: Neuralgia, Cannabis, Chronic Pain. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 166 Literaturangaben.
Abstract (Originalsprache)
Chronic neuropathic pain is a debilitating pain syndrome caused by damage to the nervous system that is poorly served by current medications. Given these problems, clinical studies have pursued extracts of the plant Cannabis sativa as alternative treatments for this condition. The vast majority of these studies have examined cannabinoids which contain the psychoactive constituent delta‐9‐tetrahydrocannabinol (THC). While there have been some positive findings, meta‐analyses of this clinical work indicates that this effectiveness is limited and hampered by side‐effects. This review focuses on how recent preclinical studies have predicted the clinical limitations of THC‐containing cannabis extracts, and importantly, point to how they might be improved. This work highlights the importance of targeting channels and receptors other than cannabinoid CB1 receptors which mediate many of the side‐effects of cannabis. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pain Management Research Institute, Kolling Institute of Medical Research, Northern Clinical School, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Eddy Sokolaj, Neda Assareh, Kristen Anderson, Karin R Aubrey, Christopher W Vaughan
Zitieren
APA
Sokolaj, E., Assareh, N., Anderson, K., Aubrey, K. R., & Vaughan, C. W. (2024). Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence. Journal of Neurochemistry. https://doi.org/10.1111/jnc.15964
Vancouver
Sokolaj E, Assareh N, Anderson K, Aubrey KR, Vaughan CW. Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence. Journal of Neurochemistry. 2024. doi:10.1111/jnc.15964
BibTeX
@article{Sokolaj2024,
author = {Sokolaj, Eddy and Assareh, Neda and Anderson, Kristen and Aubrey, Karin R and Vaughan, Christopher W},
title = {Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence},
journal = {Journal of Neurochemistry},
year = {2024},
doi = {10.1111/jnc.15964}
}
EUVIMED